Abuja, Feb. 18, 2026 – The new Harvestfield Medical Free Trade Zonein Nigeria will reduce the country’s dependence on imported medical products and also boost local production capacity.
Olufemi Ogunyemi, the Managing Director of the Nigeria Export Zone (NEPZA), made the observation while presenting the Declaration of Licence and Operational Licence to the promoters of the new zone in Abuja.
He described Harvestfield Free Trade Zone (FTZ) as a strategic intervention aimed at addressing critical gaps in the country’s health sector, noting that it aligns with the Federal Government’s push to transform Nigeria into an export-driven economy.
“Harvestfield FTZ is strategic and focused on addressing key deficits in the health sector. This opens up a new opportunity for the country to become an exporter of health products.
“The Authority consistently supports trade and investment facilitation that drives economic growth and strengthens the President’s Renewed Hope Agenda to transform the country into an export-oriented nation,” Ogunyemi said.
Abdu Mukthar, the Representative and National Coordinator of the Presidential Initiative to Unlock Healthcare Value Chains (PVAC), said the zone emerged from the Presidential Executive Order on Local Manufacturing of Healthcare Products signed in 2024 by President Bola Ahmed Tinubu.
He said the Danish conglomerate, Vestergaard, reputed as the world’s largest insecticide-treated net manufacturer, is partnering with Nigerian business group Harvestfield through a joint venture, SNG Health, to establish a production facility within the zone.
He said the partners had committed $30 million to the project with additional financial backing from smaller stakeholders.
The facility, located in Ogun State, is expected to commence operations in April 2026 and will produce 10 million dual-insecticide-treated mosquito nets annually.
Mukthar said the first phase of production will meet 30 per cent of Nigeria’s insecticide net demand and generate an estimated 600 jobs.
He said the investment is critical to Nigeria’s malaria control efforts as the country currently accounts for 27 per cent of the global malaria burden and 30 per cent of malaria-related deaths annually.
Murkthar said the new facility is expected to start production in April 2026 and supply 30% of Nigeria’s insecticide net demand during the first phase.
He said that currently, Nigeria accounts for 27% of the global malaria burden and 30% of all malaria deaths each year,
